Outcome Prediction in Patients with Glioblastoma by Using Imaging, Clinical, and Genomic Biomarkers: Focus on the Nonenhancing Component of the Tumor
Rajan Jain(NYU Langone Health), Adam E. Flanders(Jefferson University Hospitals), John Freymann(Leidos (United States)), Max Wintermark(University of Maryland, Baltimore), Lisa Scarpace, Scott N. Hwang(St. Jude Children's Research Hospital), Tom Mikkelsen(Henry Ford Health System), David A. Gutman(Emory University), Laila Poisson, Arvind Rao(Washtenaw Community College), Rivka R. Colen(The University of Texas MD Anderson Cancer Center), Chad A. Holder(Emory University Hospital), C. Carl Jaffe(University of Alabama at Birmingham), Justin Kirby
Cited by 237
Related Papers
The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS)
|IEEE Transactions on Medical Imaging|2014|6.7k
The Immune Landscape of Cancer
|Immunity|2018|6.3k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k